Catalyst Wire Dossier Catalyst Wire Dossier

autologous NK cells (expanded and activated)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for autologous NK cells (expanded and activated), covering 2016-12-05 to 2016-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma [Phase 1]

See pricing